First investor round table for the #Chemostart programme

Monday, July 9, 2018

The finalists in the #Chemostart programme designed by our Group presented their projects to a round table of investors. The pioneering shortlisted projects in this first edition of the programme – which aims to identify startups specialising in innovative healthcare solutions – were an in-vitro diagnostic test (immunobiogram) for the treatment of inflammatory diseases (BIOHOPE), a device for the treatment of urinary incontinence (BIRDI) and a non-invasive artificial pancreas to treat diabetes (MEDICSEN). The round table was attended by seven potential investors and the mentors who have accompanied and advised the entrepreneurs throughout the process.